Subtle differences in the pathogenicity of SARS-CoV-2 variants of concern B.1.1.7 and B.1.351 in rhesus macaques

SARS-CoV-2 关注变种 B.1.1.7 和 B.1.351 在恒河猴中的致病性存在细微差异

阅读:3
作者:Vincent J Munster ,Meaghan Flagg ,Manmeet Singh ,Claude Kwe Yinda ,Brandi N Williamson ,Friederike Feldmann ,Lizzette Pérez-Pérez ,Jonathan Schulz ,Beniah Brumbaugh ,Myndi G Holbrook ,Danielle R Adney ,Atsushi Okumura ,Patrick W Hanley ,Brian J Smith ,Jamie Lovaglio ,Sarah L Anzick ,Craig Martens ,Neeltje van Doremalen ,Greg Saturday ,Emmie de Wit

Abstract

The emergence of several SARS-CoV-2 variants has caused global concerns about increased transmissibility, increased pathogenicity, and decreased efficacy of medical countermeasures. Animal models can be used to assess phenotypical changes in the absence of confounding factors. Here, we compared variants of concern (VOC) B.1.1.7 and B.1.351 to a recent B.1 SARS-CoV-2 isolate containing the D614G spike substitution in the rhesus macaque model. B.1.1.7 behaved similarly to D614G with respect to clinical disease and replication in the respiratory tract. Inoculation with B.1.351 resulted in lower clinical scores, lower lung virus titers, and less severe lung lesions. In bronchoalveolar lavages, cytokines and chemokines were up-regulated on day 4 in animals inoculated with D614G and B.1.1.7 but not with B.1.351. In nasal samples, cytokines and chemokines were up-regulated only in the B.1.1.7-inoculated animals. Together, our study suggests that circulation under diverse evolutionary pressures favors transmissibility and immune evasion rather than increased pathogenicity.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。